An increased IL-31 could lead to a Th2-dominant inflammation in the early stage, but with late anti-inflammatory action in asthma [25] It is also a potential biomarker for the phenotypic classification of viral bronchiolitis, depending on the type of virus [26]. The gene discussed is IL31; the disease is asthma.